Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 76

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 76
---
 Capital Market under
the symbol “SXTP,” and warrants under the symbol “SXTPW.” Trading in our common stock has historically lacked
consistent volume, and the market price has been volatile.

On March 26, 2025 the closing price for our common
stock and warrants as reported on The Nasdaq Capital Market was $1.88 per share and $0.024, respectively.

Holders of Common Stock

On March 27, 2025, there were 21 holders of record of our common stock.

Reverse Stock Split

On November 6, 2024, our Board approved a reverse
stock split of our Common Stock at a split ratio ranging between 1:3 and 1:5, as determined by the Board in its sole discretion. On November
6, 2024, a majority of the stockholders of the Company approved the proposed reverse stock split. On February 10, 2025, the Board approved
a 1-for-5 reverse split ratio. On February 24, 2025, the Company effectuated a 1-for-5 reverse stock split of our common stock (the “1:5
Reverse Stock Split”). Beginning February 24, 2025, our common stock traded on The Nasdaq Capital Market on a split adjusted basis.

In July 2024, our Board approved a reverse stock
split of our Common Stock at a split ratio ranging between 1:5 and 1:12, as determined by the Board in its sole discretion. On July 16,
2024, a majority of the stockholders of the Company approved the proposed reverse stock split. On July 19, 2024, our Board approved a
1-for-12 reverse split ratio. On August 12, 2024, the Company effectuated a 1-for-12 reverse stock split of our common stock (the “1:12
Reverse Stock Split” and together, with the 1:5 Reverse Stock Split, the “Reverse Stock Splits”). Beginning August 12,
2024, our common stock traded on The Nasdaq Capital Market on a split adjusted basis.

All common share and applicable per share amounts in this Annual Report
on Form 10-K have been retroactively restated to reflect the effect of the Reverse Stock Splits.

Transfer Agent

The transfer agent for our common stock is Equity
Stock Transfer, LLC (“Equity Stock Transfer”), located at 237 West 37th Street, Suite 602,